1978 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2006

Early switch with aromatase inhibitors as adjuvant hormonal therapy for postmenopausal breast cancer: Pooled-analysis of 8794 patients

Bria, E., Ciccarese, M., Giannarelli, D., Cuppone, F., Nisticò, C., Nuzzo, C., Natoli, G., Fabi, A., Terzoli, E., Cognetti, F. & Carlini, P., Aug 2006, In : Cancer Treatment Reviews. 32, 5, p. 325-332 8 p.

Research output: Contribution to journalArticle

Factorial design for randomized clinical trials [6]

Bria, E., Di Maio, M., Nisticò, C., Cuppone, F., Terzoli, E., Cognetti, F. & Giannarelli, D., Oct 2006, In : Annals of Oncology. 17, 10, p. 1607-1608 2 p.

Research output: Contribution to journalArticle

Future directions in the second-line treatment of non-small cell lung cancer

Rosell, R., Cecere, F., Cognetti, F., Cuello, M., Sanchez, J. M., Taron, M., Reguart, N. & Jablons, D., Feb 2006, In : Seminars in Oncology. 33, SUPPL. 1

Research output: Contribution to journalArticle

Human malignant mesothelioma: Molecular mechanisms of pathogenesis and progression

Spugnini, E. P., Bosari, S., Citro, G., Lorenzon, I., Cognetti, F. & Baldi, A., 2006, In : International Journal of Biochemistry and Cell Biology. 38, 12, p. 2000-2004 5 p.

Research output: Contribution to journalArticle

Is anthracycline-based chemotherapy alone adequate for young women with estrogen receptor-positive breast cancer?

Papaldo, P., Di Cosimo, S., Ferretti, G., Carlini, P., Fabi, A., Cecere, F. & Cognetti, F., Apr 2006, In : Breast. 15, 2, p. 269-272 4 p.

Research output: Contribution to journalArticle

Is recurrent venous thromboembolism after therapy reduced by low-molecular-weight heparin compared with oral anticoagulants?

Ferretti, G., Bria, E., Giannarelli, D., Carlini, P., Felici, A., Mandalà, M., Papaldo, P., Fabi, A., Ciccarese, M., Cuppone, F., Cecere, F. L., Nuzzo, C., Terzoli, E. & Cognetti, F., Dec 2006, In : Chest. 130, 6, p. 1808-1816 9 p.

Research output: Contribution to journalArticle

Is there a right-sided shift for colorectal cancer in women compared with men? [2]

Ferretti, G., Felici, A., Cognetti, F. & Mandala, M., May 2006, In : Cancer Epidemiology Biomarkers and Prevention. 15, 5, p. 1054-1055 2 p.

Research output: Contribution to journalArticle

Lineage-specific hematopoietic growth factors [11]

Ferretti, G., Papaldo, P. & Cognetti, F., Aug 3 2006, In : New England Journal of Medicine. 355, 5, p. 526 1 p.

Research output: Contribution to journalArticle

Liver toxicity after treatment with gefitinib and anastrozole: drug-drug interactions through cytochrome p450?

Carlini, P., Papaldo, P., Fabi, A., Felici, A., Ruggeri, E. M., Milella, M., Ciccarese, M., Nuzzo, C., Cognetti, F. & Ferretti, G., Dec 10 2006, In : Journal of Clinical Oncology. 24, 35

Research output: Contribution to journalArticle

Molecular stool testing for the early detection of colorectal cancer: Swan song for p53? [2]

Ferretti, G., Felici, A., Ciccarese, M., Papaldo, P., Carlini, P., Fabi, A., Gelibter, A. & Cognetti, F., Jun 2006, In : Annals of Oncology. 17, 6, p. 1026 1 p.

Research output: Contribution to journalArticle

Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy: What is the appropriate use of filgrastim? [15]

Ferretti, G., Lopez, M., Terzoli, E., Cortesi, E., Antimi, M., Marolla, P., Giannarelli, D., Cognetti, F. & Papaldo, P., Dec 10 2006, In : Journal of Clinical Oncology. 24, 35, p. 5618-5619 2 p.

Research output: Contribution to journalArticle

Non-small cell lung cancer: Early stages

Bria, E., Ceribelli, A., Trovò, M. G., Gelibter, A., Gigante, M., Calabrò, E., Cuppone, F., Cognetti, F., Terzoli, E. & Pastorino, U., Apr 2006, In : Annals of Oncology. 17, SUPPL. 2

Research output: Contribution to journalArticle

Pegylated liposomal doxorubicin in combination with gemcitabine: A phase II study in anthracycline-naïve and anthracycline pretreated metastatic breast cancer patients

Fabi, A., Ferretti, G., Papaldo, P., Salesi, N., Ciccarese, M., Lorusso, V., Carlini, P., Carpino, A., Mottolese, M., Cianciulli, A. M., Giannarelli, D., Sperduti, I., Felici, A. & Cognetti, F., May 2006, In : Cancer Chemotherapy and Pharmacology. 57, 5, p. 615-623 9 p.

Research output: Contribution to journalArticle

Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma

Spugnini, E. P., Cardillo, I., Verdina, A., Crispi, S., Saviozzi, S., Calogero, R., Nebbioso, A., Altucci, L., Cortese, G., Galati, R., Chien, J., Shridhar, V., Vincenzi, B., Citro, G., Cognetti, F., Sacchi, A. & Baldi, A., Oct 15 2006, In : Clinical Cancer Research. 12, 20 PART 1, p. 6133-6143 11 p.

Research output: Contribution to journalArticle

Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patients

Garufi, C., Vanni, B., Aschelter, A. M., Zappalà, A. R., Bria, E., Nisticò, C., Sperduti, I., Cognetti, F. & Terzoli, E., Mar 2006, In : European Journal of Cancer. 42, 5, p. 608-616 9 p.

Research output: Contribution to journalArticle

Ras oncogene mutations and survival in patients with lung cancer [3]

Ferretti, G., Felici, A. & Cognetti, F., May 22 2006, In : British Journal of Cancer. 94, 10, p. 1548 1 p.

Research output: Contribution to journalArticle

Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: A pooled analysis of the randomised trials

Ferretti, G., Bria, E., Giannarelli, D., Felici, A., Papaldo, P., Fabi, A., Di Cosimo, S., Ruggeri, E. M., Milella, M., Ciccarese, M., Cecere, F. L., Gelibter, A., Nuzzo, C., Cognetti, F., Terzoli, E. & Carlini, P., Jun 19 2006, In : British Journal of Cancer. 94, 12, p. 1789-1796 8 p.

Research output: Contribution to journalArticle

Severe rhabdomyolysis associated with pemetrexed-based chemotherapy

Ceribelli, A., Cecere, F. L., Milella, M., Facciolo, F., Gelibter, A. & Cognetti, F., Apr 2006, In : The Lancet Oncology. 7, 4, p. 353 1 p.

Research output: Contribution to journalArticle

Severe skin reaction in a patient with gastrointestinal stromal tumor treated with imatinib mesylate

Ferraresi, V., Catricalà, C., Ciccarese, M., Ferrari, A., Zeuli, M. & Cognetti, F., Nov 2006, In : Anticancer Research. 26, 6 C, p. 4771-4774 4 p.

Research output: Contribution to journalArticle

Targeted therapies for patients with advanced colorectal cancer: Focus on cetuximab

Van Cutsem, E., Labianca, R., Cognetti, F. & Tabernero, J., Jan 2006, In : Targeted Oncology. 1, 1, p. 2-12 11 p.

Research output: Contribution to journalArticle

Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: Multivariate analysis of prognostic factors

Nisticò, C., Cuppone, F., Bria, E., Fornier, M., Giannarelli, D., Mottolese, M., Novelli, F., Natoli, G., Cognetti, F. & Terzoli, E., Nov 2006, In : Anti-Cancer Drugs. 17, 10, p. 1193-1200 8 p.

Research output: Contribution to journalArticle

Transforming growth factor α expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines

Pino, M. S., Shrader, M., Baker, C. H., Cognetti, F., Xiong, H. Q., Abbruzzese, J. L. & McConkey, D. J., Apr 1 2006, In : Cancer Research. 66, 7, p. 3802-3812 11 p.

Research output: Contribution to journalArticle

Trastuzumab combined with paclitaxel after doxorubicin and cyclophosphamide for operable HER2-positive breast cancer [4]

Ferretti, G., Felici, A., Papaldo, P., Carlini, P., Fabi, A. & Cognetti, F., May 2006, In : The oncologist. 11, 5, p. 533 1 p.

Research output: Contribution to journalArticle

Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: Meta-analysis of randomized trials

Bria, E., Cuppone, F., Ciccarese, M., Nisticò, C., Facciolo, F., Milella, M., Izzo, F., Terzoli, E., Cognetti, F. & Giannarelli, D., Dec 2006, In : Cancer Treatment Reviews. 32, 8, p. 583-587 5 p.

Research output: Contribution to journalArticle

Weekly paclitaxel plus capecitabine in advanced breast cancer patients: Dose-finding trial of GOIRC and GOL

Di Costanzo, F., Gasperoni, S., Papaldo, P., Bilancia, D., Manzione, L., Landucci, E., Mazzoni, F. & Cognetti, F., Jan 2006, In : Annals of Oncology. 17, 1, p. 79-84 6 p.

Research output: Contribution to journalArticle

What is the biological significance of circulating blood levels of metalloproteinases? [3]

Ferretti, G., Fabi, A., Carlini, P., Papaldo, P., Felici, A. & Cognetti, F., Jun 1 2006, In : Clinical Cancer Research. 12, 11 I, p. 3550-3551 2 p.

Research output: Contribution to journalArticle

2007

Adjuvant Chemotherapy for Bladder Cancer: The Chance for Meta-analyses Comparison

Bria, E., Ruggeri, E. M., Pollera, C. F., Terzoli, E., Cognetti, F. & Giannarelli, D., Feb 2007, In : European Urology. 51, 2, p. 576-577 2 p.

Research output: Contribution to journalArticle

Adjuvant chemotherapy for non-small cell lung cancer

Bria, E., Cuppone, F., Cecere, F. L., Milella, M., Nisticò, C., Cognetti, F. & Terzoli, E., May 2007, In : Journal of Thoracic Oncology. 2, 5 SUPPL.1

Research output: Contribution to journalArticle

Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis

Ferretti, G., Fabi, A., Carlini, P., Papaldo, P., Felici, A. & Cognetti, F., Jul 2007, In : Bone. 41, 1, p. 155-156 2 p.

Research output: Contribution to journalArticle

A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer

Geulibter, A. J., Gamucci, T., Pollera, C. F., Di Costanzo, F., Nuzzo, C., Gabriele, A., Signorelli, C., Gasperoni, S., Ferraresi, V., Giannarelli, D., Cognetti, F. & Zeuli, M., Sep 2007, In : Current Medical Research and Opinion. 23, 9, p. 2117-2123 7 p.

Research output: Contribution to journalArticle

Aromatase inhibitors in post-menopausal metastatic breast carcinoma

Carlini, P., Bria, E., Giannarelli, D., Felici, A., Papaldo, P., Fabi, A., Ruggeri, E. M., Milella, M., Nuzzo, C., Cecere, F. L., Gelibter, A., Pino, M. S., Nisticò, C., Cuppone, F., Metro, G., Terzoli, E., Cognetti, F. & Ferretti, G., Jul 2007, In : Expert Opinion on Investigational Drugs. 16, 7, p. 1023-1036 14 p.

Research output: Contribution to journalArticle

A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells

Petrucci, E., Pasquini, L., Petronelli, A., Saulle, E., Mariani, G., Riccioni, R., Biffoni, M., Ferretti, G., Benedetti-Panici, P., Cognetti, F., Scambia, G., Humphreys, R., Peschle, C. & Testa, U., May 2007, In : Gynecologic Oncology. 105, 2, p. 481-492 12 p.

Research output: Contribution to journalArticle

Bio-pathologic characteristics related to chromosome 11 aneusomy and cyclin D1 gene status in surgically resected stage I and II breast cancer: Identification of an adverse prognostic profile

Mottolese, M., Orlandi, G., Sperduti, I., Merola, R., Buglioni, S., Di Benedetto, A., Pinnarò, P., Perracchio, L., Venturo, I., Cognetti, F. & Cianciulli, A., Feb 2007, In : American Journal of Surgical Pathology. 31, 2, p. 247-254 8 p.

Research output: Contribution to journalArticle

Bone of the hands as unusual metastastatic site of renal cell carcinoma

Salesi, N., Russillo, M., Marandino, F., Ruggeri, E. M., Metro, G., Cognetti, F. & Fabi, A., Dec 2007, In : Journal of Experimental and Clinical Cancer Research. 26, 4, p. 595-597 3 p.

Research output: Contribution to journalArticle

Clinical evaluation of the use of Exemestane as further hormonal therapy after nonsteroidal aromatase inhibitors in postmenopausal metastatic breast cancer patients

Carlini, P., Michelotti, A., Ferretti, G., Ricci, S., Giannarelli, D., Pellegrini, M., Cresti, N., Cosimo, S. D., Bria, E., Papaldo, P., Fabi, A., Ruggeri, E. M., Milella, M., Alimonti, A., Salesi, N. & Cognetti, F., Mar 2007, In : Cancer Investigation. 25, 2, p. 102-105 4 p.

Research output: Contribution to journalArticle

Clinical utility of continuing trastuzumab beyond brain progression in HER-2-positive metastatic breast cancer [3]

Metro, G., Sperduti, I., Russillo, M., Milella, M., Cognetti, F. & Fabi, A., Dec 2007, In : The oncologist. 12, 12, p. 1467-1469 3 p.

Research output: Contribution to journalArticle

Exemestane or tamoxifen?

Ferretti, G., Felici, A., Carlini, P. & Cognetti, F., May 12 2007, In : Lancet. 369, 9573, p. 1599 1 p.

Research output: Contribution to journalArticle

Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study

Gridelli, C., Gallo, C., Ceribelli, A., Gebbia, V., Gamucci, T., Ciardiello, F., Carozza, F., Favaretto, A., Daniele, B., Galetta, D., Barbera, S., Rosetti, F., Rossi, A., Maione, P., Cognetti, F., Testa, A., Di Maio, M., Morabito, A. & Perrone, F., Jun 2007, In : The Lancet Oncology. 8, 6, p. 500-512 13 p.

Research output: Contribution to journalArticle

Gemcitabine-based combinations for inoperable pancreatic cancer: Have we made real progress? A meta-analysis of 20 phase 3 trials

Bria, E., Milella, M., Gelibter, A., Cuppone, F., Pino, M. S., Ruggeri, E. M., Carlini, P., Nisticò, C., Terzoli, E., Cognetti, F. & Giannarelli, D., Aug 1 2007, In : Cancer. 110, 3, p. 525-533 9 p.

Research output: Contribution to journalArticle

HER2/neu role in breast cancer: From a prognostic foe to a predictive friend

Ferretti, G., Felici, A., Papaldo, P., Fabi, A. & Cognetti, F., Feb 2007, In : Current Opinion in Obstetrics and Gynecology. 19, 1, p. 56-62 7 p.

Research output: Contribution to journalArticle

Major bleedings in the comparisons between low-molecular weight heparin versus oral anticoagulant therapy for venous thromboembolism

Ferretti, G., Bria, E., Giannarelli, D., Carlini, P., Felici, A., Mandalà, M., Ciccarese, M., Papaldo, P., Fabi, A. & Cognetti, F., 2007, In : Thrombosis Research. 119, 4, p. 525-529 5 p.

Research output: Contribution to journalArticle

MEK blockade converts AML differentiating response to retinoids into extensive apoptosis

Milella, M., Konopleva, M., Precupanu, C. M., Tabe, Y., Ricciardi, M. R., Gregorj, C., Collins, S. J., Carter, B. Z., D'Angelo, C., Petrucci, M. T., Foà, R., Cognetti, F., Tafuri, A. & Andreeff, M., Mar 1 2007, In : Blood. 109, 5, p. 2121-2129 9 p.

Research output: Contribution to journalArticle

Old age: Biologic versus chronologic [15]

Gelibter, A. J., Di Segni, S., Zeuli, M., Milella, M., Ferretti, G., Nuzzo, C. & Cognetti, F., Feb 20 2007, In : Journal of Clinical Oncology. 25, 6

Research output: Contribution to journalArticle

Overcoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies

Tortora, G., Bianco, R., Daniele, G., Ciardiello, F., McCubrey, J. A., Ricciardi, M. R., Ciuffreda, L., Cognetti, F., Tafuri, A. & Milella, M., Jun 2007, In : Drug Resistance Updates. 10, 3, p. 81-100 20 p.

Research output: Contribution to journalArticle

Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy

Roché, H., Yelle, L., Cognetti, F., Mauriac, L., Bunnell, C., Sparano, J., Kerbrat, P., Delord, J. P., Vahdat, L., Peck, R., Lebwohl, D., Ezzeddine, R. & Curé, H., Aug 10 2007, In : Journal of Clinical Oncology. 25, 23, p. 3415-3420 6 p.

Research output: Contribution to journalArticle

Pregnancy levels of estrogen and progesterone: The double-edged sword [1]

Ferretti, G., Felici, A. & Cognetti, F., Mar 2007, In : Cancer Epidemiology Biomarkers and Prevention. 16, 3, p. 634 1 p.

Research output: Contribution to journalArticle

Proteasome inhibitors sensitize ovarian cancer cells to TRAIL induced apoptosis

Saulle, E., Petronelli, A., Pasquini, L., Petrucci, E., Mariani, G., Biffoni, M., Ferretti, G., Scambia, G., Benedetti-Panici, P., Cognetti, F., Humphreys, R., Peschle, C. & Testa, U., Apr 2007, In : Apoptosis. 12, 4, p. 635-655 21 p.

Research output: Contribution to journalArticle

Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer

Gasparini, G., Gion, M., Mariani, L., Papaldo, P., Crivellari, D., Filippelli, G., Morabito, A., Silingardi, V., Torino, F., Spada, A., Zancan, M., De Sio, L., Caputo, A., Cognetti, F., Lambiase, A. & Amadori, D., Mar 2007, In : Breast Cancer Research and Treatment. 101, 3, p. 355-365 11 p.

Research output: Contribution to journalArticle